Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Other Cautions

Rarely, a few more serious side effects can occur with Copaxone and the interferon drugs. Interferon medications may increase the risk for depression -- which is already more common in people with MS. If you have a history of depression, your doctor may want to monitor you more closely while you're taking Avonex, Betaseron, Rebif, Plegridy, or Extavia. The interferon drugs can also cause liver problems and can lower the number of white blood cells, which help your body fight infection.

Another caution is with the drug Tysabri, which is used as a second-line treatment for people whose MS doesn't respond well to interferons or Copaxone. Tysabri is generally safe, but it can increase the risk for a rare but dangerous viral infection of the brain, called progressive multifocal leukoencephalopathy (PML). According to the FDA, PML incidence per 1,000 patients is 0.3 cases during the first two months of treatment, 1.5 cases during 25 to 36 months of treatment, and 0.9 during 37 to 48 months of treatment.

"Even though it's relatively rare, it's a very serious disease and often fatal or disabling, so we want to make sure we minimize the risk," Miller says. The longer patients are on this drug, the greater their risk becomes. Other conditions that increase risk for PML include AIDS, cancer, organ transplant, and chronic steroid therapy or immune suppressing therapy.

A test can help doctors assess risk for PML. The test looks for evidence of exposure to the JC virus, which causes PML. In studies, all of the people taking Tysabri who developed PML had antibodies to the JC virus. "We assume that if you don't have this virus in your body, your risk of PML would be very low," Ratchford says. "The risk is still low, even among people who are JC-positive, but it is a little higher." Having this test available could make it easier for doctors and MS patients to decide whether taking the drug is worth the risk.

Aubagio is one of the new oral treatments for MS. The most common side effects of Aubagio include diarrhea, abnormal liver tests, nausea, and hair loss. However, Aubagio does carry a “black box” warning -- the FDA’s most serious warning -- because of liver problems and birth defects. Doctors should periodically do liver function testing in those on the drug. The medication should not be taken by pregnant women.

Signs of MS Relapse

Can you recognize an MS relapse? Get the facts to help you cope.
View slideshow